
Home » Prescription Drugs 15 » STANLIP Lofibra
Fenofibrate is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and triglycerides (fatty substances) in your blood. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to your heart brain and other parts of your body. Lowering your blood level of cholesterol and fats may help to prevent heart disease angina (chest pain) strokes and heart attacks.Fenofibrate comes as a capsule to take by mouth. It is usually taken once a day with a meal. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take fenofibrate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Buy STANLIP Lofibra and other Prescription Drugs 15 products online
at Medstore.
378 Buy Online at Medstore - Click Here!

About STANLIP Lofibra:
Product Type: Prescription Drugs 15
STANLIP ( Lofibra Tricor Generic Fenofibrate)
STANLIP (Lofibra Tricor Generic Fenofibrate)
Lofibra Tricor Generic Fenofibrate
160mg tabs 100 (10 x 10)
Lofibra Tricor Generic Fenofibrate STANLIP

View more
Prescription Drugs 15
Previous Product Next Product
Without A Prescription:
Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests.
The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections.
Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed.
But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.


|